Hours of Sleep and Myocardial Infarction Risk

This is one of the first studies to prospectively assess this association, and its outcomes support the idea that poor sleep is a potential MI risk factor. 

Cantidad de horas de sueño y riesgo de infarto de miocardio

Even though we need further data to be able to modify the current sleep duration standards as part of life-style change recommendations, it seems reasonable to start bearing this in mind.

Prior observational studies have associated extremes of sleep duration (both little and too much sleep) with MI risk, but confounders have made it hard to reach a definite conclusion. 

This study assessed 461347 participants free of heart disease, classified into three groups according to reported average sleep duration (short sleep <6 hours, between 6 and 9 hours and long sleep >9 hours). Multiple confounders were assessed, even a genetic disposition for heart disease. 


Read also: Dietary Supplements and Diets Show No Impact on Cardiovascular Risk.


Compared against individuals sleeping between 6 and 9 hours, those reporting short sleep had 20% higher MI risk after adjusting for multiple variables (HR: 1.20; CI 95%: 1.07 to 1.33) and those reporting long sleep had 34% higher risk of MI (HR: 1.34; CI 95%: 1.13 to 1.58).

Conclusion

This prospective study looking at sleep duration and MI risk showed a significant association between the two in people sleeping both short and long hours. More data are needed for us to be able to make recommendations to patients as part of a prevention strategy.

Original title: Sleep Duration and Myocardial Infarction.

Reference: Iyas Daghlas et al. J Am Coll Cardiol 2019;74:1304–14.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...